RESULTS	Patients ( n = 707 ) with nonvalvular atrial fibrillation and at least 1 risk factor ( age > 75 years , hypertension , heart failure , diabetes , or prior stroke/transient ischemic attack ) were randomized to either the Watchman device ( n = 463 ) or continued warfarin ( n = 244 ) in a 2:1 ratio .\